vs
Side-by-side financial comparison of Sintx Technologies, Inc. (SINT) and SenesTech, Inc. (SNES). Click either name above to swap in a different company.
SenesTech, Inc. is the larger business by last-quarter revenue ($421.0K vs $290.0K, roughly 1.5× Sintx Technologies, Inc.). SenesTech, Inc. runs the higher net margin — -428.5% vs -763.8%, a 335.3% gap on every dollar of revenue. On growth, SenesTech, Inc. posted the faster year-over-year revenue change (-16.0% vs -46.5%). SenesTech, Inc. produced more free cash flow last quarter ($-1.7M vs $-2.4M). Over the past eight quarters, SenesTech, Inc.'s revenue compounded faster (0.7% CAGR vs -35.0%).
Sintx Technologies, Inc. is an advanced materials company specializing in R&D and manufacturing of high-performance silicon nitride and other technical ceramic products. It serves key segments including medical implants, aerospace & defense, industrial wear components, and electric vehicle applications, with core markets across North America, Europe and Asia-Pacific.
SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona.
SINT vs SNES — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $290.0K | $421.0K |
| Net Profit | $-2.2M | $-1.8M |
| Gross Margin | 64.8% | 55.3% |
| Operating Margin | -799.3% | -446.8% |
| Net Margin | -763.8% | -428.5% |
| Revenue YoY | -46.5% | -16.0% |
| Net Profit YoY | -30.7% | -43.7% |
| EPS (diluted) | $-0.50 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $290.0K | $421.0K | ||
| Q3 25 | $208.0K | $690.0K | ||
| Q2 25 | $151.0K | $625.0K | ||
| Q1 25 | $369.0K | $485.0K | ||
| Q4 24 | $542.0K | $501.0K | ||
| Q3 24 | $799.0K | $482.0K | ||
| Q2 24 | $859.0K | $459.0K | ||
| Q1 24 | $687.0K | $415.0K |
| Q4 25 | $-2.2M | $-1.8M | ||
| Q3 25 | $-3.5M | $-1.3M | ||
| Q2 25 | $-2.3M | $-1.6M | ||
| Q1 25 | $-2.3M | $-1.7M | ||
| Q4 24 | $-1.7M | $-1.3M | ||
| Q3 24 | $-6.2M | $-1.5M | ||
| Q2 24 | $-2.2M | $-1.6M | ||
| Q1 24 | $-886.0K | $-1.8M |
| Q4 25 | 64.8% | 55.3% | ||
| Q3 25 | 44.7% | 62.8% | ||
| Q2 25 | 37.7% | 65.4% | ||
| Q1 25 | 33.3% | 64.5% | ||
| Q4 24 | 71.6% | 60.9% | ||
| Q3 24 | 73.7% | 65.4% | ||
| Q2 24 | 73.9% | 54.2% | ||
| Q1 24 | 67.5% | 32.5% |
| Q4 25 | -799.3% | -446.8% | ||
| Q3 25 | -1613.0% | -195.2% | ||
| Q2 25 | -1764.9% | -258.2% | ||
| Q1 25 | -645.8% | -342.9% | ||
| Q4 24 | -319.6% | -250.9% | ||
| Q3 24 | -802.0% | -321.0% | ||
| Q2 24 | -315.5% | -349.0% | ||
| Q1 24 | -465.4% | -444.1% |
| Q4 25 | -763.8% | -428.5% | ||
| Q3 25 | -1701.4% | -188.1% | ||
| Q2 25 | -1535.1% | -258.6% | ||
| Q1 25 | -621.1% | -343.3% | ||
| Q4 24 | -312.7% | -250.5% | ||
| Q3 24 | -780.9% | -313.9% | ||
| Q2 24 | -256.6% | -345.1% | ||
| Q1 24 | -129.0% | -441.4% |
| Q4 25 | $-0.50 | $0.48 | ||
| Q3 25 | $-3.46 | $-0.28 | ||
| Q2 25 | $-0.91 | $-0.87 | ||
| Q1 25 | $-1.29 | $-1.28 | ||
| Q4 24 | $17.04 | $-0.15 | ||
| Q3 24 | $-6.96 | $-2.07 | ||
| Q2 24 | $-3.61 | $-3.08 | ||
| Q1 24 | $-21.66 | $-3.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $8.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.9M | $9.6M |
| Total Assets | $9.5M | $12.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | $8.6M | ||
| Q3 25 | $6.3M | $10.2M | ||
| Q2 25 | $4.3M | $6.1M | ||
| Q1 25 | $6.5M | $1.7M | ||
| Q4 24 | $3.6M | $1.3M | ||
| Q3 24 | $4.8M | $2.5M | ||
| Q2 24 | $4.6M | $2.0M | ||
| Q1 24 | $5.8M | $3.6M |
| Q4 25 | $2.9M | $9.6M | ||
| Q3 25 | $4.1M | $11.3M | ||
| Q2 25 | $4.0M | $7.0M | ||
| Q1 25 | $6.1M | $2.9M | ||
| Q4 24 | $3.9M | $2.5M | ||
| Q3 24 | $5.6M | $3.7M | ||
| Q2 24 | $8.8M | $3.1M | ||
| Q1 24 | $9.9M | $4.6M |
| Q4 25 | $9.5M | $12.8M | ||
| Q3 25 | $11.4M | $14.6M | ||
| Q2 25 | $9.2M | $10.4M | ||
| Q1 25 | $11.4M | $3.6M | ||
| Q4 24 | $9.4M | $3.3M | ||
| Q3 24 | $11.3M | $4.4M | ||
| Q2 24 | $15.3M | $4.0M | ||
| Q1 24 | $17.6M | $5.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.3M | $-1.7M |
| Free Cash FlowOCF − Capex | $-2.4M | $-1.7M |
| FCF MarginFCF / Revenue | -822.8% | -398.3% |
| Capex IntensityCapex / Revenue | 14.5% | 3.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-5.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.3M | $-1.7M | ||
| Q3 25 | $-2.5M | $-1.4M | ||
| Q2 25 | $-2.4M | $-1.1M | ||
| Q1 25 | $-1.3M | $-1.6M | ||
| Q4 24 | $-1.1M | $-1.2M | ||
| Q3 24 | $-2.6M | $-1.4M | ||
| Q2 24 | $-2.2M | $-1.6M | ||
| Q1 24 | $-2.7M | $-1.8M |
| Q4 25 | $-2.4M | $-1.7M | ||
| Q3 25 | $-2.6M | $-1.4M | ||
| Q2 25 | — | $-1.2M | ||
| Q1 25 | $-1.4M | $-1.6M | ||
| Q4 24 | $-1.3M | $-1.2M | ||
| Q3 24 | $-2.6M | $-1.4M | ||
| Q2 24 | $-2.6M | $-1.6M | ||
| Q1 24 | $-2.9M | $-1.8M |
| Q4 25 | -822.8% | -398.3% | ||
| Q3 25 | -1250.5% | -205.9% | ||
| Q2 25 | — | -191.5% | ||
| Q1 25 | -368.6% | -328.5% | ||
| Q4 24 | -234.3% | -246.1% | ||
| Q3 24 | -323.0% | -296.1% | ||
| Q2 24 | -299.7% | -354.2% | ||
| Q1 24 | -423.1% | -441.2% |
| Q4 25 | 14.5% | 3.1% | ||
| Q3 25 | 40.4% | 6.1% | ||
| Q2 25 | 0.0% | 7.5% | ||
| Q1 25 | 16.0% | 7.4% | ||
| Q4 24 | 26.9% | 3.0% | ||
| Q3 24 | 1.4% | 5.8% | ||
| Q2 24 | 41.8% | 8.5% | ||
| Q1 24 | 25.3% | 0.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
